Urvashi Mitbander Joshi, Jabra Zarka, Hong Wang, Yan Zang, Amy Rose, John M. Kirkwood, Jason J. Luke, Hassane M. Zarour, Diwakar Davar, Yana G. Najjar. "A phase 1/2 study of vusolimogene oderparepvec (RP1) in primary melanoma (mel) to reduce the risk of sentinel lymph node (SLN) metastasis.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps9607